Published by Josh White on 10th November 2022
(Sharecast News) - Cell engineering technology specialist MaxCyte reported total third-quarter revenue of $10.6m on Thursday, making for an increase of 5% year-on-year.
URL: http://www.digitallook.com/dl/news/story/33100319/...